Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries

References

• HarrisEDJrRheumatoid arthritis. Pathophysiology and implications for therapyN Engl J Med199032218127712892271017
   PubMed Web of Science ®Google Scholar
• SaleemBWalshCAEmeryPRemission in inflammatory arthritis: a new immunological targetImmunotherapy20113445946321463185
   PubMed Web of Science ®Google Scholar
• van VollenhovenRFTreatment of rheumatoid arthritis: state of the art 2009Nat Rev Rheumatol200951053154119798027
   PubMed Web of Science ®Google Scholar
• CurtisJRJainAAsklingJA comparison of patient characteristics and outcomes in selected European and US rheumatoid arthritis registriesSemin Arthritis Rheum2010401214. e120674669
   PubMed Web of Science ®Google Scholar
• GeborekPCrnkicMPeterssonIFSaxneTSouth Swedish Arthritis Treatment GroupEtanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern SwedenAnn Rheum Dis200261979379812176803
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudKGefellerOChoiHKPredicting mortality in patients with rheumatoid arthritisArthritis Rheum20034861530154212794820
   PubMed Web of Science ®Google Scholar
• KievitWFransenJOerlemansAJThe efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practiceAnn Rheum Dis200766111473147817426065
   PubMed Web of Science ®Google Scholar
• Global Tuberculosis Report 2014GenevaWorld Health Organization2014 Available from: http://www.who.int/tb/publications/global_report/en/Accessed September 23, 2014
   Google Scholar
• MiglioriGBCentisRProblems to control TB in eastern Europe and consequences in low incidence countriesMonaldi Arch Chest Dis2002575–628529012814043
   PubMedGoogle Scholar
• SinghJAWellsGAChristensenRAdverse effects of biologics: a network meta-analysis and Cochrane overviewCochrane Database Syst Rev20112CD00879421328309
   PubMed Web of Science ®Google Scholar
• AsklingJForedCMGeborekPSwedish registers to examine drug safety and clinical issues in RAAnn Rheum Dis200665670771216414975
   PubMed Web of Science ®Google Scholar
• MercerLKGallowayJBLuntMThe influence of anti-TNF therapy upon incidence of non-melanoma skin cancer (NMSC) in patients with rheumatoid arthritis (RA): results from the BSR Biologics Register (BSRBR) [abstract]Arthritis Rheum2009Suppl 102062
   Google Scholar
• StrangfeldAHierseFRauRRisk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBITArthritis Res Ther2010121R520064207
   PubMed Web of Science ®Google Scholar
• Gómez-ReinoJJCarmonaLValverdeVRMolaEMMonteroMDBIOBADASER GroupTreatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance reportArthritis Rheum20034882122212712905464
   PubMed Web of Science ®Google Scholar
• DescalzoMÁCarmonaLGrupo de Estudio BIOBADASERBiobadaser 2.0: analysis and trends in 2009Rheumatol Clin201065240243 Spanish
   Google Scholar
• KvienTKHeibergMSLieEA Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseasesClin Exp Rheumatol2005235 Suppl 39S188S19416273806
   PubMed Web of Science ®Google Scholar
• HetlandMLDANBIO: a nationwide registry of biological therapies in DenmarkClin Exp Rheumatol2005235 Suppl 39S205S20716273809
   PubMed Web of Science ®Google Scholar
• HetlandMLChristensenIJTarpUAll Departments of Rheumatology in DenmarkDirect comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registryArthritis Rheum2010621223220039405
   PubMed Web of Science ®Google Scholar
• DamjanovNDimicALazarevicMStefanovicDStankovicARheumatology Association of SerbiaDisease activity and working disability in 1775 patients with rheumatoid arthritis – Data from National Registry of patients with Rheumatoid Arthritis in SerbiaAnn Rheum Dis201069Suppl 367119740904
   PubMed Web of Science ®Google Scholar
• OstojicPDamjanovNDimicAImproved efficacy of rituximab in rheumatoid arthritis when administered regularly at six-month intervals – data from the Serbian registry (NARASS)Ann Rheum Dis201271Suppl 3670
   Google Scholar
• PavelkaKForejtováSStolfaJAnti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRAClin Exp Rheumatol200927695896320149312
   PubMed Web of Science ®Google Scholar
• MarchesoniAZaccaraEGorlaRTNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practiceAnn N Y Acad Sci2009117383784619758236
   PubMed Web of Science ®Google Scholar
• Du PanSMDehlerSCiureaAZiswilerHRGabayCFinckhASwiss Clinical Quality Management PhysiciansComparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritisArthritis Rheum200961556056819405000
   PubMed Web of Science ®Google Scholar
• FlouriIDrososASkopouliFLong term follow-up of RA patients of the Hellenic biologics registry: comparison of first versus second anti-TNFA therapyAnn Rheum Dis200968Suppl 3430
   Google Scholar
• KomanoYTanakaMNankiTREAL Study GroupIncidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm SafetyJ Rheumatol20113871258126421498482
   PubMed Web of Science ®Google Scholar
• KremerJThe CORRONA databaseAnn Rheum Dis200564Suppl 4iv37iv4116239384
   PubMed Web of Science ®Google Scholar
• MarietteXGottenbergJERavaudPCombeBRegistries in rheumatoid arthritis and autoimmune diseases: data from the French registriesRheumatology (Oxford)201150122222921148156
   PubMed Web of Science ®Google Scholar
• Gómez-ReinoJJCarmonaLAngel DescalzoMBiobadaser GroupRisk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infectionArthritis Rheum200757575676117530674
   PubMed Web of Science ®Google Scholar
• MarietteXMatucci-CerinicMPavelkaKMalignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysisAnn Rheum Dis201170111895190421885875
   PubMed Web of Science ®Google Scholar
• VerstappenSMKingYWatsonKDSymmonsDPHyrichKLBSRBR Control Centre Consortiu, BSR Biologics RegisterAnti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics RegisterAnn Rheum Dis201170582382621362710
   PubMed Web of Science ®Google Scholar
• StrangfeldAZinkASafety of biologic therapy - results from the German biologics register RABBITDtsch Med Wochenschr20141393718171820 German25180996
   PubMed Web of Science ®Google Scholar
• DixonWGHyrichKLWatsonKDLuntMGallowayJUstianowskiABSRBR Control Centre ConsortiumSymmonsDPBSR Biologics RegisterDrug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)Ann Rheum Dis201069352252819854715
   PubMed Web of Science ®Google Scholar
• TubachFSalmonDRavaudPResearch Axed on Tolerance of Biotherapies GroupRisk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registryArthritis Rheum20096071884189419565495
   PubMed Web of Science ®Google Scholar
• Gómez-ReinoJJCarmonaLBIOBADASER GroupSwitching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year periodArthritis Res Ther200681R2916507128
   PubMed Web of Science ®Google Scholar
• MokCCKwanCChanKYLeeKLTamLSHong Kong Society of RheumatologyRetention rate of the anti-TNF biologics in the treatment of rheumatic diseases and predictive factors for drug withdrawal: data from the Hong Kong Biologics RegistryAnn Rheum Dis201271Suppl 3663
   Google Scholar
• WolfeFMichaudKBiologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational studyArthritis Rheum20075692886289517729297
   PubMed Web of Science ®Google Scholar
• BansardCLequerréTDaveauMCan rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?Rheumatology (Oxford)20094891021102819483089
   PubMed Web of Science ®Google Scholar
• Global Tuberculosis Report 2013GenevaWorld Health Organization2013 Available from: http://apps.who.int/iris/bit-stream/10665/91355/1/9789241564656_eng.pdfAccessed March 10, 2014
   Google Scholar